Open Access

Indobufen versus aspirin in acute ischaemic stroke (INSURE): rationale and design of a multicentre randomised trial

Yuesong Pan, Xia Meng, Weiqi Chen, Jing Jing, Jinxi Lin, Yong Jiang, S Claiborne Johnston, Philip M Bath, Qiang Dong, An-Ding Xu, Hao Li, Yongjun Wang
DOI: 10.1136/svn-2021-001480 Published 20 February 2023
Submit a Response to This Article
Compose eLetter

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

Vertical Tabs

No eLetters have been published for this article.
Back to top
Email
Print
Alerts
Citation Tools
Cite This
Download PDF

Indobufen versus aspirin in acute ischaemic stroke (INSURE): rationale and design of a multicentre randomised trial
Yuesong Pan, Xia Meng, Weiqi Chen, Jing Jing, Jinxi Lin, Yong Jiang, S Claiborne Johnston, Philip M Bath, Qiang Dong, An-Ding Xu, Hao Li, Yongjun Wang
Stroke and Vascular Neurology Oct 2022, 7 (5) e001480; DOI: 10.1136/svn-2021-001480
Reddit logo Twitter logo Facebook logo Mendeley logo
Respond to this article